Cargando…
Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis
Numerous studies have demonstrated that the expression level of maternally expressed gene 3 (MEG3) was lost in various cancers. Low expression of MEG3 is associated with an increased risk of metastasis and a poor prognosis in cancer patients. This meta-analysis investigated the association between M...
Autores principales: | Cui, Xiangrong, Jing, Xuan, Long, Chunlan, Tian, Jie, Zhu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386668/ https://www.ncbi.nlm.nih.gov/pubmed/28157702 http://dx.doi.org/10.18632/oncotarget.14987 |
Ejemplares similares
-
The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
por: Liu, Jing, et al.
Publicado: (2015) -
Accuracy of the urine UCA1 for diagnosis of bladder cancer: a meta-analysis
por: Cui, Xiangrong, et al.
Publicado: (2017) -
Hypermethylated long noncoding RNA MEG3 promotes the progression of gastric cancer
por: Ding, Lei, et al.
Publicado: (2019) -
Long Noncoding RNA CCAT2 as a Potential Novel Biomarker to Predict the Clinical Outcome of Cancer Patients: A Meta-Analysis
por: Tan, Juan, et al.
Publicado: (2017) -
Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer
por: Cui, Xiangrong, et al.
Publicado: (2017)